Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
WuXi STA opens a new large scale continuous manufacturing plant
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Merck’s first microbiology application and training lab in India
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Completion of the demerger of Haleon and share consolidation of GSK
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
Subscribe To Our Newsletter & Stay Updated